- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about INCY
Recent news which mentions INCY
From Benzinga
From Benzinga
This Dividend Growth Stock Is a Screaming Buy
March 15, 2022
From Motley Fool
Insiders Buy More Than $80M Of 3 Stocks
March 11, 2022
From Benzinga
Why Are Company Insiders Buying These 7 S&P 500 Stocks?
March 08, 2022
From Benzinga
From MarketWatch
From Benzinga
CTI BioPharma's Bone Marrow Cancer Drug Scores FDA Approval
March 01, 2022
From Benzinga
Insiders Buying Incyte And 2 More Stocks
February 23, 2022
From Benzinga
7 Insider Stocks to Buy as Execs Snap Them Up
February 18, 2022
From InvestorPlace
Insiders Buy Around $112M Of 3 Stocks
February 15, 2022
From Benzinga
Oncolytics Announced Updates On Clinical Trials Of New Treatment For Triple-Negative Metastatic Breast Cancer
February 10, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2022
February 09, 2022
From Benzinga
From Benzinga
Earnings Scheduled For February 8, 2022
February 08, 2022
From Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
From MarketWatch
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
From Benzinga
1 Top Dividend Stock to Buy Right Now
January 28, 2022
From Motley Fool
Incyte Pulls Parsaclisib US Application For Lymphoma Treatment, Bows Out Solid Tumor Program With Merus
January 26, 2022
From Benzinga
2 Beaten-Down Cathie Wood Growth Stocks to Buy and Hold For 10 Years
January 25, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
January 18, 2022
From Benzinga
This Biotech Is Working With Pfizer, Merck KGaA, Roche, and Other Leaders To Develop a Better Standard of Care for Breast Cancer
January 13, 2022
From Benzinga
Cramer Shares His Thoughts On Incyte, Corning And More
December 22, 2021
From Benzinga
4 Stocks Insiders Are Buying
December 20, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.